| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/11/2002 | WO2001081627A3 N-silico-screening for docking on sub-domain iiid of hcv-ires |
| 04/11/2002 | WO2001079226A3 Haplotypes of the zfp36 gene |
| 04/11/2002 | WO2001074856A3 Wnt-7b-like polypeptides and nucleic acids encoding same |
| 04/11/2002 | WO2001073432A3 Method for detecting and/or quantifying first molecules |
| 04/11/2002 | WO2001073430A3 Identification, assessment, prevention and therapy of cancers |
| 04/11/2002 | WO2001072780A3 Polynucleotides for diagnosing mammary gland cancer |
| 04/11/2002 | WO2001071033A3 A process to determine heterozygote genomic dna duplication and deletion |
| 04/11/2002 | WO2001070174A3 Vegf-modulated genes and methods employing them |
| 04/11/2002 | WO2001068833A3 Recombinant hhv8 dna |
| 04/11/2002 | WO2001066788A3 Colorimetric mutagenized enzyme screening in microcolonies |
| 04/11/2002 | WO2001065262A3 Reagents and methods useful for detecting diseases of the breast |
| 04/11/2002 | WO2001062924A3 Human g protein-coupled receptors |
| 04/11/2002 | WO2001060844A3 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |
| 04/11/2002 | WO2001059153A3 Method for identifying substances which modulate the activity of hyperpolarisation-activated cation channels |
| 04/11/2002 | WO2001058937A3 Interferon-alpha induced genes |
| 04/11/2002 | WO2001057209A3 Novel family of proteins, called atip, nucleic sequences coding for same and uses thereof |
| 04/11/2002 | WO2001055320A3 Nucleic acids, proteins, and antibodies |
| 04/11/2002 | WO2001055316A3 Nucleic acids, proteins, and antibodies |
| 04/11/2002 | WO2001053348A3 Human polypeptides related to the vanilloid and trp families of cation channel proteins and nucleic acids encoding them |
| 04/11/2002 | WO2001042491A3 Novel enzymatic substrates for detecting pseudomonas aeruginosa |
| 04/11/2002 | WO2001022920A8 Colon and colon cancer associated polynucleotides and polypeptides |
| 04/11/2002 | WO2000073785A3 Low interference disposable sensor and method of making |
| 04/11/2002 | WO2000066781A3 Dna balls |
| 04/11/2002 | WO2000056925A3 Methods for single nucleotide polymorphism detection |
| 04/11/2002 | WO2000055373A3 Methods of screening for macrophage development modulators |
| 04/11/2002 | WO2000052210A3 Methods for targeting rna molecules |
| 04/11/2002 | WO2000047762A9 Enriched central nervous system cell populations |
| 04/11/2002 | WO2000028008A9 Modified ribulose 1,5-bisphosphate carboxylase/oxygenase |
| 04/11/2002 | US20020042927 Meiosis activating sterol augments implantation rate |
| 04/11/2002 | US20020042926 Ovary-specific genes and proteins |
| 04/11/2002 | US20020042545 Asymmetric oxidation of olefins to vicinal diol using osmium catalyst |
| 04/11/2002 | US20020042507 Process for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 04/11/2002 | US20020042502 Preparation of capped mRNA |
| 04/11/2002 | US20020042389 IGF-1 receptor interacting proteins |
| 04/11/2002 | US20020042386 Genetic engineering |
| 04/11/2002 | US20020042385 Cloning of a novel 7TM receptor AXOR-2 |
| 04/11/2002 | US20020042372 Genetic engineering; central nervous system disorders |
| 04/11/2002 | US20020042368 Integrin antagonists |
| 04/11/2002 | US20020042367 Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity and related disorders |
| 04/11/2002 | US20020042358 Sphingosine kinase, cloning, expression and methods of use |
| 04/11/2002 | US20020042146 Method for assay of analyte by adjustment of chemiluminescence |
| 04/11/2002 | US20020042144 Preventing agglomeration of bodily fluid; obtain body fluid sample, incubate with enzyme inhibitors, monitor body fluid agglomeration |
| 04/11/2002 | US20020042130 Propagating preferential aggregations; obtain aggregation, incubate with buffy coat cells, propagate, recover genetically engineered cells |
| 04/11/2002 | US20020042128 Electroprocessed fibrin-based matrices and tissues |
| 04/11/2002 | US20020042116 Polypeptide for use in the treatment of vision defects |
| 04/11/2002 | US20020042114 Novel human protein kinases |
| 04/11/2002 | US20020042112 Dna diagnostics based on mass spectrometry |
| 04/11/2002 | US20020042101 Nucleotide sequences which code enzymatic polypeptide for use in the treatment of cancer, restenosis and diabetic neuropathy |
| 04/11/2002 | US20020042100 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof |
| 04/11/2002 | US20020042096 Nucleic acids, proteins, and antibodies |
| 04/11/2002 | US20020042094 Nucleotide sequences for use in the detection and treatment cancer |
| 04/11/2002 | US20020042093 Polypeptide; for use in diagnosis, treatment or prevention of thyroid tumors and defects |
| 04/11/2002 | US20020042092 Measurement of microbiological activity in an opaque medium |
| 04/11/2002 | US20020042091 Methods and compositions for screening modulators of lipid kinases |
| 04/11/2002 | US20020042090 Subcutaneous glucose electrode |
| 04/11/2002 | US20020042086 Activating vascular system propagation; for use in the treatment of repefusion injury and bronci defects |
| 04/11/2002 | US20020042085 Produce light energy when decomposed; stable at room temperature |
| 04/11/2002 | US20020042084 Enzymatic reaction of a substrate radiolabelled at the C-terminal glutamate group detected by its binding to fluomicrospheres |
| 04/11/2002 | US20020042083 Measuring activity and identifying modulators of ubiquitin ligase enzymes |
| 04/11/2002 | US20020042078 Centrifuging microorganisms contained in medium, to form a concentrate, dissociation of the free nucleic acid by DNAse, extracting DNA and RNA, followed by chromatography, polymerase chain reaction and qualitative analysis of DNA |
| 04/11/2002 | US20020042076 Methods for gene array analysis of nuclear runoff transcripts |
| 04/11/2002 | US20020042075 Sample presentation apparatus for mass spectrometry |
| 04/11/2002 | US20020042074 Capturing a biological molecule at a surface, using a biological binding partner of the molecule that is immobilized |
| 04/11/2002 | US20020042073 Detection of cancer in humans; polymorphic microsatellite sequences for use as tools in the detection of cancer |
| 04/11/2002 | US20020042072 Method for monitoring the effect of cancer therapies |
| 04/11/2002 | US20020042071 Sequencing nucleic acid using labeled nucleotide phosphate probes |
| 04/11/2002 | US20020042070 Bio-chip, photoluminescent methods for identifying biological material, and apparatuses for use with such methods and bio-chips |
| 04/11/2002 | US20020042069 Solid support for use in the isolation of preferential particles in solution; for use in drug screening |
| 04/11/2002 | US20020042067 Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators |
| 04/11/2002 | US20020042065 Apparatus for the measurement of preferential particle in bodily fluid |
| 04/11/2002 | US20020042064 p53 binding areas |
| 04/11/2002 | US20020042063 Generating genetic maps; obtain sample, generate library, separate preferential nucleotide sequences, join nucleotide sequences to micrroarray, hybridize preferential nucleotide sequences, monitor pattern of hybridization |
| 04/11/2002 | US20020042062 Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms |
| 04/11/2002 | US20020042061 Screening for the presence of homologous nucleotide sequences; obtain sample, form complex, allow branch migration, incubate complex with binding proteins, monitor sample for signal |
| 04/11/2002 | US20020042060 Mutation detection using denaturing gradients |
| 04/11/2002 | US20020042059 Compositions and methods for analysis of nucleic acids |
| 04/11/2002 | US20020042054 Nucleotide sequences for use in the diagnosis and treatment of sleeping disorders |
| 04/11/2002 | US20020042053 Assays for human t cell lymphotrophic virus types I and II |
| 04/11/2002 | US20020042052 Method of removing nucleic acid contamination in amplification reactions |
| 04/11/2002 | US20020042051 Automated analysis of real-time nucleic acid amplification |
| 04/11/2002 | US20020042050 Methods for diagnosing glaucoma and discovering anti-glaucoma drugs |
| 04/11/2002 | US20020042049 Reagents and methods useful for detecting diseases of the breast |
| 04/11/2002 | US20020042048 Detection of preferential nucleotide sequences; obtain sequences, incubate with probes, monitor hybridization for inaccurate fitting |
| 04/11/2002 | US20020042045 METHODS FOR THE DETECTION OF HTLV-II ANTIBODIES EMPLOYIING NOVEL HTLV-II nra ENVELOPE PEPTIDES |
| 04/11/2002 | US20020042044 Cells of Dictyostelium discoideum are contacted with candidate agents and the expression of genes in the Nucleotide Excision Repair and Base Excision Repair pathways are examined |
| 04/11/2002 | US20020041876 Modulation of angiogenesis |
| 04/11/2002 | US20020041829 Apparatus and method for transferring small volumes of substances |
| 04/11/2002 | US20020040872 Device and methods for subdividing and filtering gel material and extracting molecules therefrom |
| 04/11/2002 | DE10049589A1 Composition for detecting nucleic acid mutations, comprises two groups of nucleic acid attached to flanking sequences that can form distinguishable hetero- and homo-hybrids |
| 04/11/2002 | DE10048417A1 Verbindungen mit verzweigtem Linker Compounds with branched linker |
| 04/11/2002 | DE10048009A1 Verfahren zum Nachweis von Pilzinfektionen A method for the detection of fungal infections |
| 04/11/2002 | CA2802193A1 A kit for detecting non-pathogenic or pathogenic influenza a subtype h5 virus |
| 04/11/2002 | CA2425789A1 Perilipin as a target for regulation of body weight, muscle mass and diabetes |
| 04/11/2002 | CA2425269A1 G-protein coupled receptors |
| 04/11/2002 | CA2425152A1 Highly expressible genes |
| 04/11/2002 | CA2425126A1 Lipid metabolism enzymes |
| 04/11/2002 | CA2425072A1 Wt1 fusion polypeptides and methods for wt1 immunotherapy |
| 04/11/2002 | CA2424952A1 Listeria inocua, genome and applications |
| 04/11/2002 | CA2424824A1 Renaturation, reassociation, association and hybridization of nucleic acid molecules |
| 04/11/2002 | CA2424779A1 Processes for clonal growth of hepatic progenitor cells |